Accessibility Tools

Medication Legend

℞: Medications that treat viral infections and tumors are marked with the "℞" symbol.
+: Medications that contain proteins for weight gain are marked with the "+" symbol.
++: Regenerative medications for neurogenesis are marked with the "++" symbol.

The U.S. Medical Research Army Acquisition Activity (USAMRAA) is conducting market research to identify parties capable of modernizing and providing sustained support to the Biodefense Laboratory System (BLMS) system at the U.S. Army Medical Research Institute of Infectious Disease (USAMRIID).

BLMS serves as the core system within the USAMRIID IT architecture, providing a central repository of data for personnel, projects, resources, and information for the institute. This includes an electronic, searchable repository of relevant technical and administrative information related to each research project in the institute.

BLMS also addresses reporting requirements for providing information to external agencies with interest in specific projects within the institute, such as the Defense Threat Reduction Agency (DTRA), the Medical Countermeasures (MCS) Program, and other customers.

The system further supports information management of compliance with regulations pertaining to the use of Biological Select Agents and Toxins.

Required activities include performing configuration management, patching, providing user training and technical support, and making minor configuration changes to the system. Currently, over 900 users have accounts in BLMS.

Further details are available via Solicitation Number: W81XWH-17-F-0000. The RFI response deadline is November 10, 2016.

Content Original Link:

https://globalbiodefense.com/2016/11/07/modernization-usamriid-biodefense-lab-management-system/

Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.

VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.